ARTICLE | Company News
Biogen Idec, Cardiokine deal
July 9, 2007 7:00 AM UTC
BIIB and Cardiokine partnered to develop and commercialize Cardiokine's lixivaptan to treat hyponatremia. Cardiokine will receive $50 million up front and is eligible for $170 million in milestones, ...